Phase III randomized double-blind study of single-dose fosaprepitant for prevention of cisplatin-induced nausea and vomiting.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 9021-9021
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 9629-9629
◽
2007 ◽
Vol 57
(6)
◽
pp. 501
Keyword(s):
2010 ◽
Vol 65
(Supplement 4)
◽
pp. iv41-iv51
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 6
(7)
◽
pp. 435-437
◽
Keyword(s):
2011 ◽
Vol 72
(1)
◽
pp. 1-12
◽